BCRB 2018

19/09/2018

PROMs in the evaluation of toxicity

Di Maio M, Nature 2016

• Underreporting of anticancer treatment-related toxicity by physicians

59

Effect of PROMs on QoL and survival

Basch E et al JAMA 2017;318(2):197

• On-line self-reporting of symptoms improves QoL and extends survival

766 consecutive patients initiating routine chemotherapy for a metastatic solid tumor

HR: 0,83 (95% CI: 0,70-0,99; p = ,04)

Randomization: usual care vs electronic PROMs

Median OS was 5 months longer in PROMs group (p = ,03)

60